- Home
- SRPT vs MEDP Comparison
SRPT vs MEDP Comparison
Compare SRPT & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- MEDP
- Stock Information
- Founded
- SRPT 1980
- MEDP 1992
- Country
- SRPT United States
- MEDP United States
- Employees
- SRPT N/A
- MEDP N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- SRPT Health Care
- MEDP Health Care
- Exchange
- SRPT Nasdaq
- MEDP Nasdaq
- Market Cap
- SRPT 12.2B
- MEDP 11.7B
- IPO Year
- SRPT 1997
- MEDP 2016
- Fundamental
- Price
- SRPT $120.39
- MEDP $343.64
- Analyst Decision
- SRPT Buy
- MEDP Buy
- Analyst Count
- SRPT 21
- MEDP 10
- Target Price
- SRPT $179.38
- MEDP $389.00
- AVG Volume (30 Days)
- SRPT 1.0M
- MEDP 277.5K
- Earning Date
- SRPT 11-06-2024
- MEDP 02-10-2025
- Dividend Yield
- SRPT N/A
- MEDP N/A
- EPS Growth
- SRPT N/A
- MEDP 33.84
- EPS
- SRPT 1.22
- MEDP 11.42
- Revenue
- SRPT $1,640,348,000.00
- MEDP $2,070,866,000.00
- Revenue This Year
- SRPT $50.40
- MEDP $14.01
- Revenue Next Year
- SRPT $71.44
- MEDP $5.86
- P/E Ratio
- SRPT $103.94
- MEDP $30.54
- Revenue Growth
- SRPT 48.45
- MEDP 16.24
- 52 Week Low
- SRPT $89.92
- MEDP $277.72
- 52 Week High
- SRPT $173.25
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- SRPT 50.01
- MEDP 52.65
- Support Level
- SRPT $122.12
- MEDP $340.06
- Resistance Level
- SRPT $128.73
- MEDP $359.49
- Average True Range (ATR)
- SRPT 3.87
- MEDP 9.00
- MACD
- SRPT -0.15
- MEDP 0.55
- Stochastic Oscillator
- SRPT 11.14
- MEDP 43.31
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.